Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,238 public trials 2,059 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions
Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 14 locations
View Trial Details
Completed

The Colorectal Breath Analysis (COBRA) Study

NCT03699163

Conditions
Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Cancer, +11 more
Locations
  • Homerton Hospital London, United Kingdom
  • St Mark's Hospital London, United Kingdom
  • St George's Hospital London, United Kingdom
  • Chelsea and Westminster Hospital London, United Kingdom
View Trial Details
Completed

Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens

NCT04989816

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changsha, China
  • Research Site Chengdu, China
View all 24 locations
View Trial Details
Completed

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

NCT03631407

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +19 more
Locations
  • Honor Health ( Site 0103) Scottsdale, Arizona, United States
  • California Cancer Associates for Research & Excellence ( Site 0100) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0102) Fresno, California, United States
  • Florida Cancer Specialists (South Region) - Research Office ( Site 7001) Fort Myers, Florida, United States
View Trial Details
Completed

Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)

NCT03374254

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +20 more
Locations
  • City of Hope National Medical Center ( Site 0102) Duarte, California, United States
  • Anschutz Medical Campus, Anschutz Cancer Pavilion ( Site 0106) Aurora, Colorado, United States
  • Yale Cancer Center ( Site 0108) New Haven, Connecticut, United States
  • Moffitt Cancer Center ( Site 0111) Tampa, Florida, United States
View all 14 locations
View Trial Details

Related conditions